Bioventus Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Bioventus Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q2 2024.
- Bioventus Inc. Income Tax Expense (Benefit) for the quarter ending June 29, 2024 was -$7.34M, a 2026% decline year-over-year.
- Bioventus Inc. Income Tax Expense (Benefit) for the twelve months ending June 29, 2024 was -$6.58M, a 83.6% increase year-over-year.
- Bioventus Inc. annual Income Tax Expense (Benefit) for 2023 was $85K.
- Bioventus Inc. annual Income Tax Expense (Benefit) for 2022 was -$44.4M, a 2157% decline from 2021.
- Bioventus Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.97M, a 265% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)